ICPerMed Logo
Release Date: 05.03.2024
www.icpermed.eu | twitter.com/icpermed

Close Cooperation between ICPerMed and the European Partnership for Personalised Medicine (EP PerMed)

At the EP PerMed kick-off meeting, ICPerMed members participated for the first time in the so-called Extended General Assembly of EP PerMed (ExtGeA). The meeting took place in Brussels (and online) on 24 January. The new body brings together all ICPerMed members and the EP PerMed partners to ensure close collaboration between the two initiatives aiming to promote the translation of personalised medicine into practice.

Ejner Moltzen, ICPerMed chair, reflected on the successful work of ICPerMed since its launch in 2017 and initiated a lively discussion on how ICPerMed could cooperate with EP PerMed in the future. Despite the end of EU funding for the so-called ICPerMed Secretariat, the administrative backbone of ICPerMed, the members of the initiative underlined their commitment to ICPerMed. EP PerMed will take over the general support of ICPerMed, allowing the continuation of its substantive work for PM. In the next years, the international consortium will mainly focus on all international as well as strategic and policy perspectives on personalised medicine. Thus, ICPerMed will have an even more prominent role as an international personalised medicine platform.

In order to streamline communication channels, we strongly encourage you to subscribe to the EP PerMed newsletter to keep up to date with the latest advances in research, development, innovation and implementation of personalised medicine approaches. We look forward to future collaborations with EP PerMed.

back to top

Report of the 5th ICPerMed Workshop 'Advancing Personalised Medicine through Technology Development' available

The 5th ICPerMed Workshop was dedicated to the latest developments in technology and innovation that are driving personalised medicine innovation. The workshop showcased achievements and experiences of researchers, clinicians, biotech and industry leaders, and thus provided insights on how to drive personalised medicine-related innovations in healthcare. Furthermore, examples of promising technologies, tools and perspectives were presented.

This ICPerMed workshop served as a prestigious platform for numerous distinguished stakeholders, researchers and industry professionals to converge and exchange insights on latest advancements, emerging trends, and challenges related to technologies supporting personalised medicine development, innovation and most importantly enabling personalised care. With an emphasis on collaborative learning and interdisciplinary dialogue, this event allowed important and fruitful discussions and networking.

Download Workshop Report

Slides of the held presentations are available on the event website.

A workshop video and statements of speakers as well as representatives of the European Commission and ICPerMed are also available on the website.

back to top

ICPerMed publications on “Challenges, Opportunities and Facilitators in Implementing Personalised Medicine”

ICPerMed developed a study on "Challenges, Opportunities, and Facilitators in Implementing Personalised Medicine" that outlines strategies for integrating personalised medicine into healthcare systems, aiming to improve health outcomes and create sustainable healthcare systems through research, development, innovation, and implementation. It presents identified significant hurdles for personalised medicine implementation and offers actionable recommendations for stakeholders, including healthcare professionals, policy makers, patient organisations, and researchers.

Eight major facilitators were identified:

  • Engaging relevant stakeholders in the implementation process of personalised medicine
  • Collaboration between relevant stakeholders during the implementation process of personalised medicine
  • Establishment of a national or regional common strategy
  • Infrastructure needed during the implementation process of personalised medicine
  • Education and training in personalised medicine
  • Resource allocation during the implementation process of personalised medicine
  • Regulations and legislations for personalised medicine approaches
  • Ethical considerations

The results of the study “Challenges, Opportunities and Facilitators in Implementing Personalised Medicine” can be downloaded:

  • Policy Brief
  • Full version of the analysis and recommendations
  • Methodology annexes
back to top

ICPerMed State of the Art Report 2023 published

ICPerMed publishes a State-of-the-Art report on an annual basis and seeks to facilitate the follow-up of the development of personalised medicine research and its implementation throughout Europe and beyond.

ICPerMed is continuously mapping activities in the field of personalised medicine to promote achievements and successes in research and implementation as well as to honour activities of ICPerMed member organisations. A set of initiatives and activities supporting personalised medicine development and implementation are presented in this 2023 report.

Furthermore, ICPerMed outlines shortly its activities of the past year until February 2024, like workshops, ICPerMed Family events, education and training activities, collection and presentation of Best Practices. New ICPerMed videos and publications are also available on the ICPerMed YouTube Channel. As the ICPerMed consortium is continuously growing, and attracts and welcomes more and more international partners, in this State-of-the-Art report the advantages to become an ICPerMed member and steps to be taken for membership are outlined.

In this 2023 report, the contribution of ICPerMed in the preparation of the European Partnership for Personalised Medicine (EP PerMed) proposal and the Strategic Research and Innovation Agenda for Personalised Medicine (SRIA for PM, 2023) is also outlined. The EP PerMed, that started on November 1st, 2023, is shortly presented.

Download the report

back to top

New ICPerMed Video online

ICPerMed brings together almost 50 European and international partners representing ministries, funding agencies and the European Commission. Together, we work on coordinating and fostering research to develop and evaluate personalised medicine approaches. Therefore, ICPerMed is actively interacting and connecting the personalised medicine community via meetings, public events, trainings and other activities, like communication. Since January 2024, ICPerMed counts more than 1000 followers on LinkedIn.

In a new video, ICPerMed, together with renown experts in the field, underlines the need for collaboration to enable personalised medicine to form together the future of medicine.

Facts:
  • ICPerMed started in November 2016
  • 50 funding organisations
  • 32 countries
  • 5 continents
  • 4 Working Groups: Clinical Studies in Personalised Medicine; Personalised Medicine in healthcare; Education, empowerment and engagement in Personalised Medicine; Health economic value of Personalised Medicine

ICPerMed is also represented on Twitter and LinkedIn.
Follow us on Twitter! @ICPerMed
Follow us on LinkedIn! @ICPerMed - The International Consortium for Personalised Medicine
 

Funded by
the European Union

The ICPerMed Secretariat has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 964197.

Imprint
The ICPerMed Secretariat is coordinated by:
DLR Project Management Agency
Department Health
Strategy, Science Communication, Ethics
Heinrich-Konen-Straße 1
53227 Bonn, Germany
phone +49 228 3821-1266
e-mail: icpermed@dlr.de
www.icpermed.eu |  twitter.com/icpermed |  www.DLR-PT.de

For information about data protection, please see our Privacy Policy

You receive this email because you have registered for the ICPerMed Newsletter via the ICPerMed Partnering Tool. If you want to unsubscribe please click here and change your subscription within the ICPerMed Partnering Tool.